Skip to main content
Premium Trial:

Request an Annual Quote

James Shaffer, Barbara Alving

Clinical Data announced this week that James Shaffer will be the new VP of sales and marketing in its PGxHealth division, which makes the PGxPredict line of pharmacogenetic tests.
Before joining Clinical Data, Shaffer worked at New River Pharmaceuticals, Prestwick Pharmaceuticals, GlaxoSmithKline, and Merck’s Human Health Division.

Barbara Alving has been named director of the National Center for Research Resources, part of the National Institutes of Health, the NIH said last week. 
Alving has served as the NCRR’s acting director since 2005, but NIH Director Elias Zerhouni has now officially appointed her to the position.
Alving has worked as a public health officer for the US Food and Drug Administration on the NIH campus, has been the chief of the Department of Hematology and Vascular Biology at Walter Reed Army Institute of Research, was chief of the Department of Hematology and Oncology at the Washington Hospital Center and was a director of the Division of Blood Diseases and Resources at the National Heart, Lung, and Blood Institute.
She also is a professor of Medicine at the Uniformed Services University of Health Sciences, and has been a member of various committees on hematology.

Filed under

The Scan

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.

Circulating Tumor DNA Linked to Post-Treatment Relapse in Breast Cancer

Post-treatment detection of circulating tumor DNA may identify breast cancer patients who are more likely to relapse, a new JCO Precision Oncology study finds.

Genetics Influence Level of Depression Tied to Trauma Exposure, Study Finds

Researchers examine the interplay of trauma, genetics, and major depressive disorder in JAMA Psychiatry.

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.